Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The prognostic value of neurofilament light chain in serum

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Treatment with interferon-beta (IFN-beta) increases B-cell activating factor of the TNF family (BAFF) expression in multiple sclerosis (MS), raising the concern that treatment of MS patients with IFN-beta may activate autoimmune B cells and stimulate the production of MS-associated autoantibodies.
Original languageEnglish
JournalMultiple Sclerosis
Volume17
Issue number5
Pages (from-to)567-77
Number of pages11
ISSN1352-4585
DOIs
Publication statusPublished - 1 May 2011

ID: 32672948